83 related articles for article (PubMed ID: 26679360)
1. c-Jun, pc-Jun, and p27 are differently expressed in oral leukoplakias in smokers and never-smokers.
Lima JS; Correa L; Klingbeil MF; de Sousa SC
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Jan; 121(1):73-80. PubMed ID: 26679360
[TBL] [Abstract][Full Text] [Related]
2. Correlation between c-Jun and human papillomavirus in oral premalignant and malignant lesions.
Acay RR; dos Santos E; de Sousa SO
Oral Oncol; 2008 Jul; 44(7):698-702. PubMed ID: 18061529
[TBL] [Abstract][Full Text] [Related]
3. Oral leukoplakia manifests differently in smokers and non-smokers.
Lima JS; Pinto Ddos S; Sousa SO; Corrêa L
Braz Oral Res; 2012; 26(6):543-9. PubMed ID: 23019086
[TBL] [Abstract][Full Text] [Related]
4. Assessment of c-Jun, c-Fos and cyclin D1 in premalignant and malignant oral lesions.
Turatti E; da Costa Neves A; de Magalhães MH; de Sousa SO
J Oral Sci; 2005 Jun; 47(2):71-6. PubMed ID: 16050486
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of EGFR in oral leukoplakia: association with clinicopathological features and cellular proliferation.
Ribeiro DC; Gleber-Netto FO; Sousa SF; Bernardes VD; Guimarães-Abreu MH; Aguiar MC
Med Oral Patol Oral Cir Bucal; 2012 Sep; 17(5):e739-44. PubMed ID: 22322523
[TBL] [Abstract][Full Text] [Related]
6. MCM3 could be a better marker than Ki-67 for evaluation of dysplastic oral lesions: an immunohistochemical study.
Lameira AG; Pontes FS; Guimarães DM; Alves AC; de Jesus AS; Pontes HA; Pinto Ddos S
J Oral Pathol Med; 2014 Jul; 43(6):427-34. PubMed ID: 24456424
[TBL] [Abstract][Full Text] [Related]
7. Long-term treatment outcome of oral premalignant lesions.
Holmstrup P; Vedtofte P; Reibel J; Stoltze K
Oral Oncol; 2006 May; 42(5):461-74. PubMed ID: 16316774
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of cornulin, keratin 4, keratin 13 expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.
Schaaij-Visser TB; Bremmer JF; Braakhuis BJ; Heck AJ; Slijper M; van der Waal I; Brakenhoff RH
Oral Oncol; 2010 Feb; 46(2):123-7. PubMed ID: 20036603
[TBL] [Abstract][Full Text] [Related]
9. Use of fuzzy neural networks in modeling relationships of HPV infection with apoptotic and proliferation markers in potentially malignant oral lesions.
Campisi G; Di Fede O; Giovannelli L; Capra G; Greco I; Calvino F; Maria Florena A; Lo Muzio L
Oral Oncol; 2005 Nov; 41(10):994-1004. PubMed ID: 16129653
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic aspects of oral leukoplakia in smokers and nonsmokers.
Freitas MD; Blanco-Carrión A; Gándara-Vila P; Antúnez-López J; García-García A; Gándara Rey JM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Aug; 102(2):199-203. PubMed ID: 16876063
[TBL] [Abstract][Full Text] [Related]
11. Quantitative assessment of expression of cell adhesion molecule (CD44) splice variants: CD44 standard (CD44s) and v5, v6 isoforms in oral leukoplakias: an immunohistochemical study.
Godge PY; Poonja LS
Indian J Dent Res; 2011; 22(3):493-4. PubMed ID: 22048598
[TBL] [Abstract][Full Text] [Related]
12. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma.
Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958
[TBL] [Abstract][Full Text] [Related]
13. Expression of p27 and apoptosis in oral leukoplakia.
Tsuzuki H; Fujieda S; Sunaga H; Narita N; Tokuriki M; Saito H
Anticancer Res; 2003; 23(2B):1265-70. PubMed ID: 12820381
[TBL] [Abstract][Full Text] [Related]
14. [Clinicopathological characteristics of malignant transformation in 85 cases of oral leukoplakia].
Gao Y; Guo ZL; Luo HY; Wang J
Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Jul; 47(7):410-3. PubMed ID: 22931571
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of cell-cycle proteins in gastric precancerous lesions.
Anagnostopoulos GK; Stefanou D; Arkoumani E; Karagiannis J; Paraskeva K; Chalkley L; Habilomati E; Tsianos E; Agnantis NJ
J Gastroenterol Hepatol; 2008 Apr; 23(4):626-31. PubMed ID: 18397488
[TBL] [Abstract][Full Text] [Related]
16. A long-term follow-up study on the natural course of oral leukoplakia in a Swedish population-based sample.
Roosaar A; Yin L; Johansson AL; Sandborgh-Englund G; Nyrén O; Axéll T
J Oral Pathol Med; 2007 Feb; 36(2):78-82. PubMed ID: 17238968
[TBL] [Abstract][Full Text] [Related]
17. Mature dendritic cell density is affected by smoking habit, lesion size, and epithelial dysplasia in oral leukoplakia samples.
Souto GR; Matias MDP; Nunes LFM; Ferreira RC; Mesquita RA
Arch Oral Biol; 2018 Nov; 95():51-57. PubMed ID: 30056280
[TBL] [Abstract][Full Text] [Related]
18. Urban legends series: oral leukoplakia.
Arduino PG; Bagan J; El-Naggar AK; Carrozzo M
Oral Dis; 2013 Oct; 19(7):642-59. PubMed ID: 23379968
[TBL] [Abstract][Full Text] [Related]
19. hMLH1 immunoexpression is related to the degree of epithelial dysplasia in oral leukoplakia.
Caldeira PC; Abreu MH; Batista AC; do Carmo MA
J Oral Pathol Med; 2011 Feb; 40(2):153-9. PubMed ID: 20969633
[TBL] [Abstract][Full Text] [Related]
20. Correlation between clinical and pathologic diagnosis in oral leukoplakia in 54 patients.
Vázquez-Álvarez R; Fernández-González F; Gándara-Vila P; Reboiras-López D; García-García A; Gándara-Rey JM
Med Oral Patol Oral Cir Bucal; 2010 Nov; 15(6):e832-8. PubMed ID: 20711115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
